Stocks and Investing Stocks and Investing
Tue, March 26, 2024

David Nierengarten Maintained (STRO) at Buy with Decreased Target to $8 on, Mar 26th, 2024


Published on 2024-10-28 09:53:51 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "Sutro Biopharma, Inc." (STRO) at Buy with Decreased Target from $12 to $8 on, Mar 26th, 2024.

David, nor any peers, have made any analyst calls on STRO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources